PLUS INJECTIONS LIMITED
54 ALEXANDRA ROAD, ENFIELD  EN3 7EH- Active - Proposal to Strike off
- Private Limited Company
- Company No. 11528204
- Last Updated: 01 Mar 2024
Company Profile
PLUS INJECTIONS LIMITED was incorporated on Tuesday, August 21, 2018 as a Private Limited Company with registered address in ENFIELD. PLUS INJECTIONS LIMITED has the status: Active - Proposal to Strike off and it's listed in the following category: Non-specialised wholesale trade. This Private Limited Company has been operating for 6 years 2 months and 20 days.
Name | PLUS INJECTIONS LIMITED |
---|---|
Company number | 11528204 |
Company type | Private Limited Company |
Incorporation date | 21 Aug 2018 |
Status | Active - Proposal to Strike off |
Industry (SIC 2007) |
Address
Registered Address |
54 ALEXANDRA ROAD ENFIELD EN3 7EH |
---|---|
Country Of Origin | ENGLAND |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
Name | Nature of Control |
---|---|
Mr Larry Ashton Nationality: British |
Dates: Tuesday, August 1, 2023 - present
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
right to appoint and remove directors as firm
significant influence or control as firm
|
Mr Samir Basim Mosawi Nationality: British |
Dates: Tuesday, August 21, 2018 - Tuesday, August 1, 2023
ownership of shares 75 to 100 percent
voting rights 75 to 100 percent
right to appoint and remove directors
|
Accounts and Confirmation
Type of accounts | TOTAL EXEMPTION FULL |
---|---|
End of financial Year | 31 August |
Next annual accounts due | 31 May 2022, (-894 days left) |
Latest accounts | 31 August 2020 |
Next confirmation statement due | 18 September 2019 |
Last confirmation statement dated | Not available |
Mortgages
No mortgages have been registered against PLUS INJECTIONS LIMITED.
Previous Names
Name | Change Date |
---|---|
PLUS INJECTIONS LIMITED | 21 Aug 2018 |
S&J PLUS LIMITED | 21 Feb 2024 |